These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24875751)

  • 1. Molecular characteristics of patients with glycosaminoglycan storage disorders in Russia.
    Chistiakov DA; Savost'anov KV; Kuzenkova LM; Gevorkyan AK; Pushkov AA; Nikitin AG; Pakhomov AV; Vashakmadze ND; Zhurkova NV; Podkletnova TV; Mayansky NA; Namazova-Baranova LS; Baranov AA
    Clin Chim Acta; 2014 Sep; 436():112-20. PubMed ID: 24875751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of 355 mucopolysaccharidosis patients reveals 104 novel mutations.
    Pollard LM; Jones JR; Wood TC
    J Inherit Metab Dis; 2013 Mar; 36(2):179-87. PubMed ID: 22976768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy.
    Yogalingam G; Guo XH; Muller VJ; Brooks DA; Clements PR; Kakkis ED; Hopwood JJ
    Hum Mutat; 2004 Sep; 24(3):199-207. PubMed ID: 15300847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical, machine learning and molecular approaches for the differential diagnosis of Mucopolysaccharidoses.
    Kadali S; Naushad SM; Radha Rama Devi A; Bodiga VL
    Mol Cell Biochem; 2019 Aug; 458(1-2):27-37. PubMed ID: 30903511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separation of sulfated urinary glycosaminoglycans by high-resolution electrophoresis for isotyping of mucopolysaccharidoses in Malaysia.
    Nor A; Zabedah MY; Norsiah MD; Ngu LH; Suhaila AR
    Malays J Pathol; 2010 Jun; 32(1):35-42. PubMed ID: 20614724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between severity of mucopolysaccharidoses and combination of the residual enzyme activity and efficiency of glycosaminoglycan synthesis.
    Piotrowska E; Jakóbkiewicz-Banecka J; Tylki-Szymańska A; Czartoryska B; Wegrzyn A; Wegrzyn G
    Acta Paediatr; 2009 Apr; 98(4):743-9. PubMed ID: 19046346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic analysis of 17 children with Hunter syndrome: identification and functional characterization of four novel mutations in the iduronate-2-sulfatase gene.
    Chistiakov DA; Kuzenkova LM; Savost'anov KV; Gevorkyan AK; Pushkov AA; Nikitin AG; Vashakmadze ND; Zhurkova NV; Podkletnova TV; Namazova-Baranova LS; Baranov AA
    J Genet Genomics; 2014 Apr; 41(4):197-203. PubMed ID: 24780617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic testing of Mucopolysaccharidoses disease using multiplex PCR- based panels of STR markers: in silico analysis of novel mutations.
    Shafaat M; Hashemi M; Majd A; Abiri M; Zeinali S
    Metab Brain Dis; 2019 Oct; 34(5):1447-1455. PubMed ID: 31236806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and molecular analysis of mucopolysaccharidoses in Turkey.
    Emre S; Terzioğlu M; Coşkun T; Tokath A; Ozalp I; Müller V; Hopwood J
    Turk J Pediatr; 2002; 44(1):13-7. PubMed ID: 11858372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Putative biological mechanisms of efficiency of substrate reduction therapies for mucopolysaccharidoses.
    Banecka-Majkutewicz Z; Jakóbkiewicz-Banecka J; Gabig-Cimińska M; Węgrzyn A; Węgrzyn G
    Arch Immunol Ther Exp (Warsz); 2012 Dec; 60(6):461-8. PubMed ID: 22949095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, biochemical and molecular features of Iranian families with mucopolysaccharidosis: A case series.
    Yassaee VR; Hashemi-Gorji F; Miryounesi M; Rezayi A; Ravesh Z; Yassaee F; Salehpour S
    Clin Chim Acta; 2017 Nov; 474():88-95. PubMed ID: 28844463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of 105 mucopolysaccharidosis type VI patients.
    Karageorgos L; Brooks DA; Pollard A; Melville EL; Hein LK; Clements PR; Ketteridge D; Swiedler SJ; Beck M; Giugliani R; Harmatz P; Wraith JE; Guffon N; Leão Teles E; Sá Miranda MC; Hopwood JJ
    Hum Mutat; 2007 Sep; 28(9):897-903. PubMed ID: 17458871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A general model for genetic regulation of turnover of glycosaminoglycans suggests a possible procedure for prediction of severity and clinical progress of mucopolysaccharidoses.
    Wegrzyn G; Wegrzyn A; Tylki-Szymańska A
    Med Hypotheses; 2004; 62(6):986-92. PubMed ID: 15142662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of the molecular lesion causing mucopolysaccharidosis type I in cats.
    He X; Li CM; Simonaro CM; Wan Q; Haskins ME; Desnick RJ; Schuchman EH
    Mol Genet Metab; 1999 Jun; 67(2):106-12. PubMed ID: 10356309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport, enzymatic activity, and stability of mutant sulfamidase (SGSH) identified in patients with mucopolysaccharidosis type III A.
    Muschol N; Storch S; Ballhausen D; Beesley C; Westermann JC; Gal A; Ullrich K; Hopwood JJ; Winchester B; Braulke T
    Hum Mutat; 2004 Jun; 23(6):559-66. PubMed ID: 15146460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-dimensional NMR spectroscopy of urinary glycosaminoglycans from patients with different mucopolysaccharidoses.
    Hochuli M; Wüthrich K; Steinmann B
    NMR Biomed; 2003 Jun; 16(4):224-36. PubMed ID: 14558120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation in VPS33A affects metabolism of glycosaminoglycans: a new type of mucopolysaccharidosis with severe systemic symptoms.
    Kondo H; Maksimova N; Otomo T; Kato H; Imai A; Asano Y; Kobayashi K; Nojima S; Nakaya A; Hamada Y; Irahara K; Gurinova E; Sukhomyasova A; Nogovicina A; Savvina M; Yoshimori T; Ozono K; Sakai N
    Hum Mol Genet; 2017 Jan; 26(1):173-183. PubMed ID: 28013294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of mucopolysaccharidosis type VI patients undergoing a trial of enzyme replacement therapy.
    Karageorgos L; Harmatz P; Simon J; Pollard A; Clements PR; Brooks DA; Hopwood JJ
    Hum Mutat; 2004 Mar; 23(3):229-33. PubMed ID: 14974081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary glycosaminoglycan excretion in healthy subjects and in patients with mucopolysaccharidoses.
    Gallegos-Arreola MP; Machorro-Lazo MV; Flores-Martínez SE; Zúñiga-González GM; Figuera LE; González-Noriega A; Sánchez-Corona J
    Arch Med Res; 2000; 31(5):505-10. PubMed ID: 11179586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: characterization and basis of a diagnostic test for MPS.
    Byers S; Rozaklis T; Brumfield LK; Ranieri E; Hopwood JJ
    Mol Genet Metab; 1998 Dec; 65(4):282-90. PubMed ID: 9889015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.